688073 Bide Pharmatech
- 47.20
- -0.65-1.36%
Bide Pharmatech News
Bide Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Bide Pharmaceutical: Self-inspection report on the 2024 Restricted Stock Incentive Plan insider\'s stock trading situation
Bide Pharmaceutical: Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Legal Opinion of Beijing Guofeng Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Self-inspection report on the 2024 Restricted Stock Incentive Plan insider\'s stock trading situation
Haitong Securities Co., Ltd. inspection opinions on the departure of core technicians of Shanghai Bide Pharmaceutical Technology Co., Ltd. and the addition of certified core technicians
Bide Pharmaceutical: Explanation of the review opinions and disclosure of the supervisory board of Shanghai Bide Pharmaceutical Technology Co., Ltd. on the list of incentive recipients granted for the first time in the company\'s 2024 restricted stock incentive plan
Explanation of the review opinions and publicity of the board of supervisors of Shanghai Bide Pharmaceutical Technology Co., Ltd. on the list of incentive recipients granted for the first time in the company\'s 2024 restricted stock incentive plan
Bide Pharmaceutical: 2025 First Extraordinary General Meeting of Shareholders Meeting Information
Announcement on the resignation of the company\'s core technical personnel and the addition of certified core technical personnel
Bide Pharmaceuticals: Bide Pharmaceuticals: 2024 Restricted Stock Incentive Plan (Draft)
Bide Pharmaceuticals: 2024 Restricted Stock Incentive Plan (Draft)
The Company\'s 2024 Restricted Stock Incentive Plan granted a list of incentive recipients for the first time
Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Announcement of Resolutions of the 10th Meeting of the 2nd Board of Supervisors
2024 Restricted Stock Incentive Plan Implementation Assessment Management Measures
Supervisory Board\'s Review Opinions on the Company\'s 2024 Restricted Stock Incentive Plan (Draft)
Announcement of Resolutions of the 13th Meeting of the 2nd Board of Directors
Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on the 2024 Restricted Stock Incentive Plan (Draft) of Shanghai Bide Pharmaceutical Technology Co., Ltd.
No Data